KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,356,000 | -15.6% | 987,204 | -6.6% | 0.00% | 0.0% |
| Q2 2018 | $3,974,000 | +1.8% | 1,056,811 | +10.7% | 0.00% | 0.0% |
| Q1 2018 | $3,905,000 | -11.0% | 954,797 | +1.2% | 0.00% | 0.0% |
| Q4 2017 | $4,389,000 | -36.5% | 943,863 | -3.0% | 0.00% | -50.0% |
| Q3 2017 | $6,910,000 | -0.8% | 973,229 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $6,963,000 | +21.5% | 963,054 | +3.5% | 0.00% | 0.0% |
| Q1 2017 | $5,732,000 | -29.4% | 930,367 | -32.8% | 0.00% | 0.0% |
| Q4 2016 | $8,118,000 | +37.1% | 1,385,386 | +24.2% | 0.00% | 0.0% |
| Q3 2016 | $5,922,000 | -5.4% | 1,115,068 | +18.0% | 0.00% | 0.0% |
| Q2 2016 | $6,257,000 | +32.4% | 945,132 | -6.6% | 0.00% | +100.0% |
| Q1 2016 | $4,727,000 | -8.3% | 1,012,362 | -0.8% | 0.00% | -50.0% |
| Q4 2015 | $5,156,000 | +50.9% | 1,020,976 | +5.2% | 0.00% | +100.0% |
| Q3 2015 | $3,417,000 | -68.9% | 970,941 | -11.7% | 0.00% | -66.7% |
| Q2 2015 | $10,975,000 | -9.8% | 1,099,805 | +15.1% | 0.00% | 0.0% |
| Q1 2015 | $12,163,000 | +11.0% | 955,439 | +23.3% | 0.00% | 0.0% |
| Q4 2014 | $10,962,000 | +5.7% | 774,675 | +2.7% | 0.00% | 0.0% |
| Q3 2014 | $10,371,000 | -34.2% | 754,240 | -26.5% | 0.00% | +50.0% |
| Q2 2014 | $15,772,000 | +73.0% | 1,025,540 | +91.7% | 0.00% | 0.0% |
| Q1 2014 | $9,116,000 | +42.3% | 534,932 | +8.1% | 0.00% | 0.0% |
| Q4 2013 | $6,406,000 | -35.2% | 494,740 | -49.5% | 0.00% | +100.0% |
| Q3 2013 | $9,880,000 | +188.6% | 979,078 | +113.6% | 0.00% | 0.0% |
| Q2 2013 | $3,424,000 | – | 458,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |